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Background: Recent reviews conclude an association between traffic-related pollution and incidence of asthma in
children, but not all studies agree. Studies have almost exclusively relied on parental-reported symptoms or
parental-reported diagnoses of asthma and wheeze. Our aim was to investigate if traffic exposure is associated with
higher incidence of early onset asthma, using registry-based outcome data.
Methods: We investigated a birth cohort in southern Sweden, consisting of N = 26 128 children with outcome and
exposure data (born July 2005–2010). Of these children, N = 7898 had additional covariate information. The cohort
was followed to the end of 2011.
Traffic intensity, and dispersion-modeled concentrations of NOX (100×100 m grid), at residential addresses, were
linked with registry data on dispensed asthma medication (the Swedish Prescribed Drug Register), and hospital and
primary health care diagnoses of bronchiolitis, obstructive bronchitis and asthma (The Scania Health Care Register).
Covariate information was obtained from questionnaires distributed to parents at Child Health Care-centre visits,
eight months after birth. Cox proportional hazards regression was used for the statistical analyses.
Results: Living in close proximity to a road with ≥8640 cars/day (compared to 0–8640 cars/day), was not
associated with higher incidence of first purchase of inhaled β2-agonist (adjusted hazard ratio (adj.HR) = 0.9, 95%
CI: 0.8-1.0); third year purchase of inhaled β2-agonist (adj.HR = 0.7, 95% CI: 0.6-0.9); bronchiolitis (adj.HR = 0.7, 95%
CI: 0.6-0.9), obstructive bronchitis (adj.HR = 1.0, 95% CI: 0.9-1.2), or asthma (adj.HR = 0.7, 95% CI: 0.6- 0.9). Similar
results were found for inhaled corticosteroids, and in relation to NOX.
Conclusions: Traffic-related exposure was not associated with higher incidence of asthma medication, or diagnoses
of asthma, bronchiolitis, or obstructive bronchitis, in children 0–6 years in southern Sweden. This may depend on
the low levels of traffic pollution in the area, mainly well below the WHO-guideline for NO2.
Keywords: Air pollution, Asthma, Bronchitis, Children, Environmental, Epidemiology, GIS, Nitrogen oxides, Roadway
proximity, TrafficBackground
It is well known that traffic-related air pollution can trig-
ger asthma symptoms in children and adults [1]. There
is also increasing evidence that long-term exposure to
traffic exhaust increases the incidence of asthma devel-
opment in children. Recent reviews conclude that living
close to a major road is associated with higher asthma
incidence in children, although there is not evidence to
conclude a casual relation [2,3].* Correspondence: anna.lindgren@med.lu.se
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reproduction in any medium, provided the orAsthmatic symptoms in children, sometimes termed
“wheeze” or “obstructive respiratory symptoms”, has di-
verse etiology. Before the age of 3 years, asthmatic symp-
toms are mainly due to respiratory virus infections,
while after 3 years, asthma due to allergic sensitization is
more often the cause [4]. Early asthmatic symptoms,
“wheeze”, to some degree predict later asthma [5]. Traf-
fic has been connected to both early [6,7], and late child-
hood asthma incidence [8-12].
For children, asthmatic symptoms, “wheeze”, are not
clinically distinct disease entities, but rather clinically
similar wheezing symptoms which becomes classified ac-
cording to age and other characteristics. Bronchiolitis isal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ive bronchitis is a diagnosis used for single episodes of
wheezing symptoms for children mainly younger than
3 years, when nothing speaks for allergic etiology.
Asthma is a diagnosis often used for a third episode of
wheezing symptoms, or for a first episode when the
child is older, the parents are known to be allergic, or
the child has had atopic eczema which speaks for an
allergic heredity [13]. The above statement refers to
common diagnostic practice in Sweden but practice
may differ between countries.
The first line of treatment for obstructive wheezing
symptoms is inhaled β2-agonists, which is prescribed for
all of the mentioned diagnoses and give immediate relief
by dilating the airways. Inhaled corticosteroids, which
has a more preventive anti-inflammatory effect, is pre-
scribed as an additional medication for treatment of
repeated wheeze or wheeze with suspected allergic com-
ponent and is considered more specific for asthma.
Some studies have used inhaled β2-agonists/corticoste-
roids as a proxy for asthma incidence [14,15].
Studies on long-term effects of traffic on asthma, how-
ever, have traditionally relied on parental-reports of
wheeze or parental-reports on diagnosis of asthma. Clin-
ical asthma examinations cannot be performed in small
children due to compliance difficulties [16], and have
not been performed in cohort studies on traffic pollution
and asthma incidence in older children either, probably
because of the cost and effort required which would re-
sult in a small sample size. Due to the risk of awareness
bias in parental-reported data [17], and the risk of over-
estimation of effects in small samples [18], there is a
need for registry-based studies which can have both ob-
jective outcome data and a larger sample size.
The Swedish Prescribed Drug Register has a complete
(99.7%) coverage of individual-level dispensed medica-
tion for all individuals living in Sweden, and dispensed
asthma medication will in this study be used as a proxy
variable for incidence of asthma. We also used diagnosis
of bronchiolitis, obstructive bronchitis, and asthma,
from the Scania Health Care Register (SHCR), which
covers inpatient and outpatient care in the region, from
hospitals as well as primary health care centers. How-
ever, the SHCR has less complete coverage and will
therefore be used as a secondary outcome. This is the
first study to use dispensed medication to estimate long-
term effects from traffic-related exposure on asthma,
and only one study has used hospital and primary health
care registries for this purpose before [8].
The overall study aim was to investigate if children
growing up close to high traffic intensity or high levels
of nitrogen oxides (NOX) are at higher risk of develop-
ing asthma or other obstructive respiratory disease,
“wheezing”, in early childhood.Methods
Study area
Scania is the southernmost county of Sweden, with a
population of 1 243 329 in year 2010 [19]. Children
born in Scania, whose mothers were registered as living
in the municipalities Malmö, Svedala, Vellinge or
Trelleborg were included, since survey data with covari-
ate information were available from Child Health Care
centers (CHC) in this area. Malmö is the major munici-
pality in the county, 298 963 inhabitants, with a large
socio-economically disadvantaged immigrant population,
30.2% foreign born. Previous studies have found that im-
migrants,and children residing in areas with low income,
has a higher exposure to NO2 in Malmö [20,21].
Malmö has the highest level of air pollution in the
area. Although pollutant levels in the region are low in a
European context (Additional file 1), they are higher
than in most of Sweden, due to long-range transport of
pollutants from the continent and extensive harbor and
ferry traffic.
Selection of study population
A flow-chart of the study population selection is dis-
played in Figure 1. The study was limited in time to
children born from July 2005, since individual level
medication data is only available since then. All children
were followed to the end of 2011.
To identify a birth cohort, we retrospectively retrieved
the identity number of all children born by mothers liv-
ing in Malmö, Svedala, Vellinge and Trelleborg during
July 2005–2010, from the Perinatal Revision South
(PNS)-registry. The PNS registry has a 100% coverage of
visits on obstetric and peri/prenatal units in the county.
Out of 28 037 children identified in the PNS-register,
875 were not found in the Scania population registry
and thus excluded, since they were not registered as liv-
ing in the region during childhood. Outcome data was
available for all children found in the Scania population
registry (n = 27 162), by linkage to the SHCR and the
Swedish Prescribed Drug Register. Geographical coordi-
nates (geocodes) for registered birth year address was
available for 26 128 children, for which exposure was
assessed. Most of the missing geocodes belonged to chil-
dren born in December, whose late birth date probably
lead to addresses not being registered during year of
birth. Geocodes were retrieved for birth year and subse-
quent years for each child, until the end of 2010. Finally,
covariate information from questionnaires routinely dis-
tributed at Child Health Care centers was available for
7898 children, which formed the main study cohort.
Ethical permission
This study was approved by the Lund University Ethical
Committee (registration no. 2011/468). No formal
Outcome data 
n=27 162 The Scania 
population registry. Linked to
the Swedish Prescribed Drug
Register and SHCR.
Exposure data
n=26 128 Geocoded address
for birth year, July 2005-2010.
Exposure at birth address:
Traffic intensity n=26 128
Modeled NOX n=26 105
Covariate data 
n=7898 answered CHC-
questionnaire at 8 months of
age, born July 2005-2009.




n=28 037 PNS-registry, born to
mothers living in the study
region, July 2005-2010.
Excluded: n=875 Not found in 
the Scania population registry.
n=79 Stillborn
n=796 Never  registered 
address in Scania
Excluded: n=1034 Address for 
birth year not registered.  
Excluded from main
analysis: n=18 230 No 
CHC-questionnaire data.
Figure 1 Selection of study population.
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tised in the local newspaper and information was distrib-
uted to Child Health Care centers, allowing parents to
request that their children not be included in it. No such
request was raised.
Asthma medication
The Swedish Prescribed Drug Register includes all
drugs dispensed at pharmacies in Sweden, since July
2005 linked to personal identity numbers [22]. The
registry is maintained by the National Board of
Health and Welfare. All expedited drugs on the phar-
macies are registered, with a very small number of
incorrect or incomplete registrations of ID. The
population coverage with correct patient identities is
99.7% [23].
The registry contains data on all dispensed prescrip-
tions in ambulatory care. Over-the-counter (OTC) medi-
cations and drugs used at inpatient settings are notincluded. Medication data are classified according to the
Anatomical Therapeutic Chemical (ATC) Classification
System [24].
The Pharmaceutical Benefit Scheme, which is mainly
tax financed, covers the main costs for drugs in ambula-
tory care in Sweden. There is a ceiling on the total
amount that a patient pays during a 12-month period
for subsidized pharmaceuticals (2013: SEK 2200, €252).
The drug costs of children younger than 18 years, living
in the same household, are counted together.
We obtained information on medications prescribed
for obstructive airways disease (ATC-code R03).
The outcomes used were dispensed prescription of
inhaled β2-agonist (ATC-codes: R03AC, R03AK04,
R03AK06, R03AK07), and inhaled corticosteroids
(ATC-codes: R03BA, R03AK06, R03AK07). Drugs with
code R03AK06 and R03AK07 are combinations of β2-ag-
onists and corticosteroids and therefore occur in both
outcomes.
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1) Incidence of first ever dispensed inhaled β2-agonist.
2) Incidence of third year with dispensed inhaled
β2-agonist.
3) Incidence of first ever dispensed inhaled
corticosteroid.
4) Incidence of third year with dispensed inhaled
corticosteroid.
First dispensed medication was seen as a proxy for
incidence of obstructive respiratory disease, but may
reflect primarily transient disease. Third year with dis-
pensed medication was seen as a proxy for more persist-
ent disease. The three years were not necessarily
consecutive years.
Diagnoses of bronchiolitis, obstructive bronchitis, and
asthma
In Sweden, all healthcare consultations are recorded in
county-specific databases. The SHCR holds details for
primary health care, and hospital based in- and out-
patient care for Scania. In Sweden, all patients are
registered to a general primary care practice. However,
patients are not obliged to attend primary care before
seeing a specialist, although that is the most common
procedure [25].
Each consultation generates data entries that are trans-
ferred to SHCR and which constitute the basis for reim-
bursement to the healthcare providers. The hospital care
has a good coverage and validity for diagnostic codes
[25,26]. However, for primary care, the number of consul-
tations with diagnostic codes is less complete. The diag-
nostic codes from public care are transferred to SHCR,
but have some missing registration of diagnostic codes
due to incomplete journal entries. For private health care
providers, consultation events, but not diagnostic codes,
are transferred to SHCR. Private care makes up approxi-
mately 30% of all primary care in Scania [25].
The number of visits that lacked diagnostic codes was
only provided on overall level for the children in this
study, not individual level.
The hospital-based health care uses a Swedish version
of the diagnostic ICD-10 system, ICD-10-SE, and the
primary health care uses a simplified version, KSH97-P.
As secondary outcomes we used diagnostic codes from
SHCR, including hospital-based as well as primary
health care. Visits are often given multiple diagnostic
codes, but we included only the primary diagnostic code.
The secondary outcomes were primary diagnoses of:
1) Bronchiolitis (J210, J218, J219),
2) Obstructive bronchitis (J200-J209, J22-P)
3) Asthma (J450- J459, J45-P, J469)Exposure assessment
Geocodes for the children’s officially registered residen-
tial addresses were retrieved from the population regis-
try, for each year from birth until the end of 2010.
Individuals are positioned at the center coordinate of
their residence.
Traffic intensity
A Geographical Information System based registry, from
the Swedish National Road Database, provided data on
traffic intensity on all major roads in the county. To as-
sess exposure to traffic, we identified the road with the
heaviest traffic intensity within 100 m of the residence.
Traffic intensity was categorized as “no road”, “road with
0–2880 cars/day”, “2880–8640 cars/day”, “8640–14400
cars/day”, and “≥14400 cars/day”, based upon daily (24-
hour) mean levels.
The traffic intensity categories were merged into a di-
chotomous variable, “0-8640 cars/day” (including chil-
dren with “no road”) and “≥8640 cars/day”, to obtain
enough power, since not enough cases lived in the high-
est exposure category to assess it separately. The classifi-
cation was based upon results from previous studies in
the same geographical region, which found a higher
prevalence of asthma among adults living within 100 m
of roads with ≥8640 cars/day [27,28]. Separate analyses
were done in relation to traffic intensity for: 1) birth ad-
dress exposure 2) birth address exposure, with children
censored when/if they moved during time at risk.
Modeled concentrations of NOx
Concentrations of NOX (NO2 + NO) at each child’s resi-
dential address, were modeled as annual means for each
calendar year 2005–2010, with a spatial resolution of
100×100 m. Concentrations were obtained from an
emission database (EDB) for NOX, previously described
in detail [20]. The emission sources included were: road
traffic, shipping, aviation, railroads, industries and larger
energy and heat producers, small-scale heating, working
machineries, working vehicles and working tools. Back-
ground levels of NOX due to transport of pollutants
from the continent, were also included, based on data
from rural background monitor stations, and meteoro-
logical factors were incorporated. For dispersion calcula-
tions, the EDB was combined with a modified Gaussian
two-dimensional dispersion model (AERMOD). Bilinear
interpolation was applied. Validation of the EDB showed
satisfying agreement between modeled and measured
concentrations of NO2 (Spearman’s r = 0.8) [29].
Separate NOX -analyses were done for: 1) birth address
exposure 2) birth address exposure, with children cen-
sored when/if they moved during time at risk, and 3)
mean NOX during all years at risk (excluding 2011 for
which geocodes were not available). The mean NOX
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moving outside the study area during time at risk. Since
time at risk differ with outcome, the number with mod-
eled mean NOX during time at risk, also vary depending
on outcome.
We used a categorical classification of NOX, since pre-
vious studies in the same geographical region have indi-
cated non-linear relationship between NOX and asthma
[27,28]. We based our categories on exposure contrasts
(≤15, 15–25 and >25 μg/m3), rather than on the distri-
bution of NOX among the population.
Covariate information
The final cohort for the main analysis included 7898
children born in the region, whose parents had answered
a CHC center questionnaire 8 months after birth. The
questionnaire was handed out to parents in Malmö, Sve-
dala, Vellinge and Trelleborg, in conjunction with their
children’s 8 month checkup at the CHC centers [30].
The questionnaire had been validated and translated
from Swedish into five different languages: Albanian,
Arabic, English, Serbo-Croatian, and Somali. The re-
sponse rate varied between years but was approximately
65% of handed out questionnaires [30].
Variables considered for inclusion in the multivariable
models were: sex, birth weight, smoking during preg-
nancy, environmental tobacco smoke (ETS), mold at
home, parental allergy, furred pets at home, breastfeed-
ing, parental origin, parental education, problems to pay
bills, type of housing, and birth year.
Statistical analysis
All statistical analyses were performed using SAS, ver-
sion 9.3. Survival analysis was performed because of dif-
ferent lengths of follow-up of the children. We used two
different censoring variables: 1) children were censored
at year of study end (2011), or 2) children were censored
when they moved from their original birth address, or at
year of study end (2011).
Descriptive Kaplan-Meier survival curves, with num-
bers at risk, were displayed for all outcomes. The pro-
portional hazard assumptions for exposure and outcome
were checked graphically by log(−log(survival))-curves.
We then reported unadjusted Cox proportional hazards-
ratios (Cox PH) between exposure and outcomes.
We used prescreening of variables in combination
with a stepwise Cox PH-procedure, to select covariates
to include in the final multivariable models. We per-
formed the same selection procedure for all outcomes in
relation to traffic intensity, to find the most important
predictors. Any variable staying in any of the outcome
models, was included in all the models, for model
consistency. Traffic intensity was forced to remain in the
model in each step. The following steps were done:1. Univariable prescreening of all covariates in Table 1,
except city. Any variable with a univariate p-value <
0.2 for the HR between the covariate and the
outcome, was selected to next step.
2. All the selected variables were included into a
multivariable Cox model, together with traffic
intensity which was forced to stay in the model.
Backward selection was performed, with significance
level for staying (Slstay) = 0.1.
3. Starting with an initial model including the
variables selected from step 2. Forward selection
was performed, with significance level for entry
(Slentry) = 0.2, to consider for inclusion the
variables initially not selected at step 1.
4. Starting with the model selected from step 3.
Finetuning was done by stepwise selection- Slentry/
Slstay 0.05. The variables selected to be included in
the final multivariable models were: Sex, ETS,
breastfeeding, parental allergy, parental origin,
parental education and year of birth.
Since all selected covariates approximately fulfilled the
PH-assumption, we used the Cox PH model for the final
multivariable analyses, to assess the incidence of asthma
medication and diagnoses in relation to traffic-related
exposures. Multivariable analyses presented do not in-
clude children with missing values for any of the vari-
ables included.
We also performed sensitivity analyses: we analyzed
the unadjusted relation between traffic-related exposure
and outcomes, for all children with complete informa-
tion on exposure and outcome (n = 26 128). For the
main cohort (n = 7898), we separately estimated effects
for Malmö vs. the remaining study area, to see if results
were consistent across geographical regions. We also
performed an analysis excluding children born 2006, the
year when most children had high traffic exposure. Finally,
we performed analyses restricted to children with high
socio-economic status (n = 3464), here defined as children
whose parents fulfilled all the following criteria; never
problems to pay bills, at least one parent with >12 years
education, and both parents born in Sweden. The question
about ability to pay bills was here not dichotomized as in
the main analysis, but instead a finer original classification
was used, where “never problems to pay bills” was sepa-
rated from “seldom problems to pay bills”.
The hazard ratios (HR) in all analyses were displayed
with 95% confidence intervals (CI).
Results
Covariate description
Population characteristics, and incidence of inhaled β2-
agonists in relation to these characteristics, are displayed
in Table 1. Most of the risk factors included in the
Table 1 Description of the main cohort, n = 7898
N (%) HR (95% CI)a
1st purchase, inhaled β2-agonist
Sex Girl 3784 (49) 1.0
Boy 3996 (51) 1.3 (1.2–1.5)
Missing 118
Birth weight 2500–4000 (normal) 6079 (78) 1.0
500–2499 (low) 301 (4) 1.1 (0.9–1.5)
4001–6500 (high) 1396 (18) 1.1 (1.0–1.3)
Missing 122
Smoking during pregnancy No 7275 (94) 1.0
Yes 499 (6) 1.2 (1.0–1.5)
Missing 124
Environmental tobacco smoke No 6591 (85) 1.0
Yes 1177 (15) 1.2 (1.1–1.4)
Missing 130
Breastfeeding ≥8 months 3920 (56) 1.0
<8 months 2807 (40) 1.2 (1.1–1.3)
Never breastfed 278 (4) 1.3 (1.0–1.6)
Missing 893
Parental allergy No 3177 (46) 1.0
Yes 3751 (54) 1.2 (1.1–1.4)
Missing 970
Furred pets at home No 5790 (75) 1.0
Yes 1922 (25) 1.0 (0.9–1.1)
Missing 186
Mold at home No 7326 (95) 1.0
Yes 386 (5) 1.0 (0.8–1.3)
Missing 186
Problems to pay bills Never or seldom 7361 (96) 1.0
Yes, >6 months/year 348 (5) 0.8 (0.6–1.0)
Missing 189
Swedish parents Yes, both Swedish 4811 (62) 1.0
One foreign 1290 (17) 0.9 (0.8–1.1)
Both foreign 1689 (22) 0.8 (0.7–1.0)
Missing 108
Highest education any parent >12 years 5612 (73) 1.0
9–12 years 1792 (23) 1.1 (1.0–1.3)
≤ 9 years 297 (4) 1.1 (0.8–1.4)
Missing 197
Type of housing Owned house 2783 (36) 1.0
Tenant-owned apartment 2242 (29) 0.9 (0.8–1.0)
Rented apartment 2616 (34) 0.9 (0.8–1.1)
Other 101 (1) 0.7 (0.4–1.1)
Missing 156
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Figure 2 Distribution of modeled annual mean NOx at birth
address, by traffic intensity (n = 7895). Upper and lower borders
of boxplots represent the 75th and 25th percentiles and the bold
line is the median. The whiskers extend to the minimum and
maximum of the NOx-concentrations.
Table 1 Description of the main cohort, n = 7898 (Continued)
City Vellinge 449 (6) 1.0
Svedala 664 (8) 0.9 (0.7–1.2)
Trelleborg 611 (8) 1.1 (0.8–1.4)
Malmö 6134 (78) 0.8 (0.6–1.0)
Missing 40
Birth year 2005 1066 (14) 1.0
2006 2395 (30) 1.1 (0.9–1.3)
2007 1664 (21) 1.0 (0.8–1.2)
2008 2179 (28) 1.0 (0.9–1.2)
2009 594 (8) 1.2 (0.9–1.5)
aUnadjusted.
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to roads with low traffic intensity (parental allergy, ETS,
no or little breastfeeding, short parental education).
Male sex of the child was associated with high traffic in-
tensity. Parental origin, and year of birth had no consist-
ent relation to traffic, but a large proportion of the
children with high traffic intensity and high NOX were
born in 2006.
Exposure description
The percentage of the study population living ≤100 m
from a traffic intensity of 0–8640 cars/day at birth ad-
dress was 73.8%, compared to 26.2% with traffic inten-
sity of ≥ 8640 cars/day at birth address. We classified
modeled NOX levels into ≤15, 15–25 and >25 μg/m
3.
For exposure at birth address, the percentage of the
population living in respective category was 34%, 57%
and 9%. Mean NOX at birth year was 17 μg/m
3, and the
percentile distribution was 9.2, 11.8, 17.6, 21.1, and
24.6 μg/m3 (10th, 25th, 50th, 75th, and 90th percentile).
Min, Max = (6.1, 45.9) μg/m3. The distribution of NOX
by traffic intensity, is displayed in Figure 2.
Missing outcome data and Kaplan-Meier survival curves
Diagnostic codes were available for 97% of the hospital
visits, and for 50% of the primary care visits. Among the
latter, 70% of public primary care visits had diagnostic
codes, while codes were completely missing for private
primary care visits. The proportion of private primary
care was 28% of total primary care visits.
Kaplan Meier survival curves, and life table data,
showed that most of the incidence of first dispensed
asthma medication and diagnoses, occurred in age
1–2 years (Additional file 1: Table S5 and Additional
file 2). The oldest children were followed to age 6 years.
Incidence of dispensed medication
Incidence of purchased inhaled β2-agonist, and inhaled
corticosteroids, was lower for children living close to aroad with ≥8640 cars/day (compared to 0–8640 cars/
day) at birth address (Table 2). Both first and third year
purchase was associated with a lower traffic intensity, in
some cases significantly so. Similar results were observed
in relation to NOX. The results were consistent for chil-
dren who never moved during time at risk, for mean
NOX during time at risk, and both before and after ad-
justment for covariates (Table 2, and Additional file 1).
Incidence of bronchiolitis, obstructive bronchitis and
asthma
There was a significantly lower incidence of diagnoses of
bronchiolitis, and asthma, but not obstructive bronchitis,
among children living close to a road with ≥8640 cars/
day (compared to 0–8640 cars/day) at birth address
(Table 2). Similar results were observed in relation to
NOX. The results were consistent for children who never
moved during time at risk, and for mean NOX during
Table 2 Adjusted HR (95% CI) for asthma medication and diagnoses, in relation to traffic-related exposure, n = 7898
Inhaled asthma medicationa Diagnosesa
β2-agonist β2-agonist Corticosteroid Corticosteroid Bronchiolitis Obstructive
bronchitis
Asthma
1st purchase 3rd year 1st purchase 3rd year
Heaviest road ≤100 m, birth addressb
0–8640 cars/day 1.0 1.0 1.0 1.0 1.0 1.0 1.0
≥8640 cars/day 0.9 (0.8–1.0) 0.7 (0.6– 0.9) 0.8 (0.7–0.9) 0.8 (0.6–1.0) 0.7 (0.6–0.9) 1.0 (0.9–1.2) 0.7 (0.6–0.9)
Heaviest road ≤100 m, never movedb
0–8640 cars/day 1.0 1.0 1.0 1.0 1.0 1.0 1.0
≥8640 cars/day 0.9 (0.7–1.0) 0.7 (0.5–1.0) 0.8 (0.6–0.9) 0.9 (0.6–1.2) 0.7 (0.6–0.9) 1.0 (0.8–1.2) 0.7 (0.6–0.9)
NOX, birth address
c
≤15 μg/m3 1.0 1.0 1.0 1.0 1.0 1.0 1.0
15–25 0.8 (0.7–1.0) 0.7 (0.5–0.8) 0.8 (0.7–0.9) 0.7 (0.5–0.9) 0.6 (0.5–0.8) 1.1 (0.9–1.3) 0.8 (0.7–0.9)
>25 0.7 (0.6–0.9) 0.6 (0.4–0.8) 0.7 (0.5–0.9) 0.6 (0.4–0.8) 0.5 (0.4–0.8) 1.1 (0.8–1.4) 0.7 (0.5–0.9)
NOX, never moved
c
≤15 μg/m3 1.0 1.0 1.0 1.0 1.0 1.0 1.0
15–25 0.8 (0.7–1.0) 0.6 (0.4–0.8) 0.8 (0.7–0.9) 0.6 (0.4–0.8) 0.6 (0.5–0.8) 1.1 (0.9–1.3) 0.8 (0.7–0.9)
>25 0.8 (0.6–1.0) 0.5 (0.3–0.9) 0.6 (0.5–0.8) 0.5 (0.3–0.9) 0.5 (0.4–0.8) 1.1 (0.8–1.5) 0.7 (0.5–0.9)
NOX, lifetime mean
d
≤15 μg/m3 1.0 1.0 1.0 1.0 1.0 1.0 1.0
15–25 0.8 (0.7–0.9) 0.7 (0.6–0.9) 0.7 (0.6–0.9) 0.7 (0.6–0.9) 0.7 (0.5–0.8) 0.9 (0.8–1.1) 0.7 (0.6–0.9)
>25 0.8 (0.6–1.1) 0.5 (0.3–0.9) 0.6 (0.5–0.9) 0.5 (0.3–0.9) 0.7 (0.5–1.0) 1.0 (0.7–1.3) 0.7 (0.5–1.0)
aadjusted for sex, ETS, breastfeeding, parental allergy, parental origin, parental education, and year of birth.
bn = 6007 children had complete covariate information and traffic exposure assessments.
cn = 6005 children had complete covariate information and modeled NOX concentrations.
dnumber of children with complete covariate information and modeled mean NOX during time at risk varies between n = 5194-5248 depending on outcome.
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adjustment for covariates, except the HR for obstructive
bronchitis, which diminished with adjustment (Table 2,
and Additional file 1).
Sensitivity analyses
An analysis of all children for which outcome and expos-
ure data was available (n = 26 128), unadjusted for any fac-
tors, showed that traffic-related exposure was statistically
significantly associated with a lower incidence of all out-
comes except obstructive bronchitis, for which the HR
was not significantly different from 1 (Additional file 1).
For the main cohort (children with covariate informa-
tion, n = 7898), we stratified our analyses separately for
Malmö vs. the remaining region, and the results were
largely consistent across the regions (data not shown).
The results were also consistent when excluding chil-
dren born 2006. Finally, we performed an analysis
restricted to children with high socio-economic status
(n = 3464) and the results for this subgroup were similar
to the results for the main cohort (Additional file 1).
Discussion
There was no increased purchase of asthma medication
or diagnosis of bronchiolitis, obstructive bronchitis orasthma among children 0–6 years, growing up close to a
road with high traffic intensity, or high levels of NOX.
On the contrary, there was a lower incidence for all out-
comes except obstructive bronchitis, among these chil-
dren. This indicates that traffic-related exposure is not a
risk factor for early onset asthma/wheeze in children in
southern Sweden.
Strengths and limitations
A strength of the study was the register-based outcome
data with complete coverage of dispensed medication,
which prevents potential awareness bias due to parental-
reported outcomes. There are still some possibilities of
selection bias due to questionnaire data in this study,
since the confounder information was only available
through CHC-questionnaires, which is likely to have
lead to a selection towards high socio-economic status
among those who answered the CHC-questionnaire. A
potential limitation was that the drug register only in-
cludes dispensed medication. The observed lower inci-
dence of medication among children in households with
bad economy or with immigrant parents in the present
study, raise a suspicion they cannot afford to dispense
prescribed medication (or do not get diagnosed in the
first place), to the same degree as the children in
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Swedish children found low socio-economic status to be
related to higher incidence of late onset wheeze, when
based on self-reported data of diagnosis or wheeze [31].
However, a recent Swedish study did not find income to
be a predictor for dispense of drugs, after controlling for
health status, but there was higher prescription rate to-
ward people with high education [32]. However, since
we had individual level data on socio-economic status
we could address this by adjustment and restriction on
different socio-economic indices, which did not affect
the result, and thus this is not a likely source of bias for
the results in our study. Another limitation was that a
non-negligible percentage of the health care visit data
lacked diagnostic codes, which could possibly cause a
bias which we cannot account for. This is also why we
treated it as a secondary outcome only, which supports
the results from the medication data, but cannot be fully
trusted on its own.
That the results for the larger study population were
the same as for the cohort with questionnaire informa-
tion strengthens that there is a higher incidence of
wheeze in areas with low traffic pollution in the region.
It is implausible that air pollution would be “protecting”
against asthma, and the results therefore speaks for the
presence of unmeasured risk factors, or different health-
seeking behavior, in areas with low traffic pollution.
Another strength was the exposure data in this study.
Residential addresses for each year since birth were
known, which exclude a migration bias which could
otherwise be expected to dilute the effects. We also had
validated high quality exposure data for NOx, modeled
with a high resolution, which further minimize the risk
of other exposure misclassification biases which could
be expected to dilute the effects.
The levels of modeled NOX at children’s home address
in this study were low compared to other studies,
despite the high resolution of the grid, which can be
expected to increase the exposure range [33]. Since
different studies use different measures of traffic expos-
ure, complicating comparisons, we also provide a table
with background levels of air pollution in the region, to
give a picture of the exposure situation in the area
(Additional file 1).
We believe the quality of exposure data is better than
in most other studies which have found a relation be-
tween traffic and wheeze, we therefore see it as unlikely
that poor quality of exposure data would be the cause of
the negative findings in our study.
Comparison with other studies
Recent reviews conclude that there is, overall, evidence
for a relation between long-term exposure to traffic and
asthma incidence in children [2,3]. However, not allindividual studies agree, and little differentiation has
been made in reviews according to age of asthma onset.
We think there is more evidence for an association with
persistent wheeze and later onset asthma, than with
early onset asthma/wheeze. At least in the studies in the
Nordic countries which is where the exposure situation
is similar to our study. A cohort study in Norway had
similar finding to our study, with a negative association
between NO2 and early onset asthma (RR = 0.8, 95% CI:
0.6-1.0) [34]. However, late onset asthma (≥4 years age),
had a positive but non-significant association with NO2.
A Swedish cohort study also found no association be-
tween NOX and transient early wheeze before 2 years
age (OR = 0.8, 95% CI: 0.5-1.4), but a positive association
with persistent wheeze [35], and a positive association
with asthma onset at age 12 [10].
Some studies outside the Nordic countries have found
associations between traffic-related exposures and inci-
dence of wheeze or early asthma [6,7], but others have
not [36,37]. In a Dutch birth cohort, NO2 was not asso-
ciated with incident asthma at age 2, but was associated
with asthma incidence in older age [9].
In contrast, cohort studies in older children seems to
have found more consistent results for traffic-related ex-
posure to be associated with asthma incidence [9-12].
Clark et al. 2010 used hospital and primary care diagno-
sis records, and found a relation between NO2 and
asthma incidence already at ages 3–4 years [8]. However,
this study had more restrictive case definition of asthma
compared to our study, reflecting more severe or persist-
ent asthma.
It should be noted that numerous studies with positive
associations between traffic-related exposure and asthma
incidence are still statistically non-significant [3]. These
studies have in reviews still been interpreted as contrib-
uting evidence for a relation between traffic-related
exposure and asthma. Our study on the contrary, was
based on large numbers and can thus rule out positive
effects with high statistical certainty. However, con-
founding can never be fully excluded. We also want to
point out that the exposure levels in our study were
lower than most other studies, something which could
also explain the lack of effect.
We think that our study together with the results from
previous studies in the Nordic countries, suggests that
traffic exposure, at the levels observed, either is not a
risk factor for incidence of early onset wheeze or
asthma, or that the effects may be so small that they are
easily overridden by other risk factors. However, the
situation may be different in countries with higher ex-
posure to traffic pollution. Also, it should be kept in
mind that the results from our study does not exclude
effects on late-onset asthma in children, or wheeze that
persists into older age. This cohort should be followed
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and later-onset of childhood asthma, or persistent
wheeze continuing into older age.
Conclusions
We found no association between growing up close to
traffic and higher incidence of dispensed asthma medica-
tion, diagnosis of bronchiolitis, obstructive bronchitis or
asthma, in children 0–6 years in southern Sweden. This
indicates that traffic-related exposure is not a risk factor
for early onset asthma, or “wheeze”, in southern Sweden,
something which may depend on the low levels of
traffic-related air pollution in the area.
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Additional file 1: Table S1. Urban background. Descriptive data of
regional air pollution at monitoring station in Malmö. Table S2.
Unadjusted HR (95% CI) for asthma medication and diagnoses, in relation
to traffic-related exposure, n = 7898. Table S3. Sensitivity analysis
including all children with outcome and exposure data, n = 26128.
Table S4. Sensitivity analysis of children with high socio-economic
status a, n = 3464. Table S5. Life table data.
Additional file 2: Kaplan-Meier survival curves of asthma
medication and diagnoses in relation to traffic intensity, with
number at risk.
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